Virpax Pharmaceuticals CEO Anthony Mack's 2023 pay jumps 55% to $1.2M
Virpax Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: December 9, 2024
Virpax Pharmaceuticals reported fiscal year 2023 executive compensation information on December 9, 2024.
In 2023, five executives at Virpax Pharmaceuticals received on average a compensation package of $531K, a 4% increase compared to previous year.
Average pay of disclosed executives at Virpax Pharmaceuticals
Anthony Mack, Chief Executive Officer, received $1.2M in total, which increased by 55% compared to 2022.
Sheila A. Mathias, Chief Scientific Officer, received a compensation package of $498K. 62% of the compensation package, or $308K, was in salary.
Christopher Chipman, Chief Financial Officer, earned $491K in 2023, a 5% increase compared to previous year.
Vinay Shah, Chief Financial Officer, received $324K in 2023.
Gerald W. Bruce, Chief Executive Officer, earned $128K in 2023.
Related executives
You may also like
Source: SEC filing on December 9, 2024.